Cite
MLA Citation
Mathilde Cancel et al.. “Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Génitales).” European journal of cancer, vol. 158, 2021, pp. 1–11. http://access.bl.uk/ark:/81055/vdc_100145646523.0x000028